Arcus Biosciences Inc (RCUS)
Total asset turnover
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 117,000 | 112,000 | 382,882 | 77,517 | 15,000 |
| Total assets | US$ in thousands | 1,095,000 | 1,345,000 | 1,592,000 | 772,292 | 203,110 |
| Total asset turnover | 0.11 | 0.08 | 0.24 | 0.10 | 0.07 |
December 31, 2023 calculation
Total asset turnover = Revenue ÷ Total assets
= $117,000K ÷ $1,095,000K
= 0.11
The total asset turnover ratio of Arcus Biosciences Inc has shown fluctuations over the past five years. This ratio indicates the company's efficiency in generating sales revenue relative to its total assets.
In 2023, the total asset turnover ratio was 0.11, which suggests that the company generated $0.11 in sales for every $1 of total assets. This represents an improvement from the previous year when the ratio was 0.08.
Comparing to 2021 when the ratio was 0.24, the efficiency of asset utilization seems to have declined significantly in 2023. However, it is worth noting that the ratio in 2021 was unusually high, indicating a peak in efficiency that might have been influenced by specific factors during that year.
Overall, the total asset turnover ratio for Arcus Biosciences Inc has been fluctuating, and it is important to further analyze the company's operations and business strategy to understand the reasons behind these variations and assess the efficiency of the company in utilizing its assets to generate sales revenue.
Peer comparison
Dec 31, 2023